Immunofluorescence analysis of cerebral microvascular density in APP/PS1 mice

Exploratory Score: 0.900 Price: $0.50 Alzheimer's disease 1-month-old APP/PS1 mice and wild-type controls Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting N/A in 1-month-old APP/PS1 mice and wild-type controls. Primary outcome: cerebral microvascular density and average vessel length

Description

Immunofluorescence staining for CD31 was performed on cerebral cortical sections from 1-month-old APP/PS1 and wild-type mice to assess cerebral microvascular density and vessel morphology. This histological analysis aimed to characterize early microvascular changes in a mouse model of Alzheimer's disease by quantifying vessel density and average vessel length in the cerebral cortex.

TARGET GENE
N/A
MODEL SYSTEM
1-month-old APP/PS1 mice and wild-type controls
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
cerebral microvasculature
SOURCE
extracted_from_pmid_41940832
PRIMARY OUTCOME
cerebral microvascular density and average vessel length

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

APP→Amyloid-beta→Plaque→Alzheimer's Disease CausalpathwayAPP/PS1 Dual Transgenic Mouse ModelmodelAPP — Amyloid Precursor ProteingeneAPP Gene Dosage Reduction Therapy for Down SyndromideaAPP Amyloid Pathway in Alzheimer's DiseasemechanismAPP/PS1 Double Transgenic Mouse ModelmechanismAPP GenegeneAPP Arctic Mutation (APP Arctic)diseaseAPP Dutch Mutation (APP Dutch)diseaseAPP Flemish Mutation (APP Flemish)diseaseAPP-Overexpressing NeuronscellAPP Swedish Mutation (APPswe)mutationAPP-BACE1-Fe65 ComplexmechanismAPP Processing and Amyloid-Beta ProductionmechanismAPP Proteinprotein

Protocol

Immunofluorescence staining for CD31 on cerebral cortical sections with quantitative analysis of vessel parameters

Expected Outcomes

Reduced microvascular density in early-stage AD mice

Success Criteria

Significant differences in microvascular density and vessel length between APP/PS1 and WT mice

Related Hypotheses (5)

TREM2-mediated microglial tau clearance enhancement0.594
LRP1-Dependent Tau Uptake Disruption0.576
VCP-Mediated Autophagy Enhancement0.571
Extracellular Vesicle Biogenesis Modulation0.558
HSP90-Tau Disaggregation Complex Enhancement0.551

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.